The effects of local hyperthermia on the catabolism of a radioiodinated chimeric monoclonal antibody

Clinical Cancer Research

Volumn 4, Issue 9, 1998, Pages 2071-2077

  Hauck, Marlene L ^a,b   Zalutsky, Michael R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB;

ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CATABOLISM; GLIOMA; GLOMERULUS FILTRATION; HUMAN; HYPERTHERMIA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RADIOACTIVITY; RADIOIODINATION; URINARY EXCRETION;

ANIMALS; ANTIBODIES, MONOCLONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLIOMA; HUMANS; HYPERTHERMIA, INDUCED; IMMUNOTOXINS; IODINE RADIOISOTOPES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECOMBINANT FUSION PROTEINS; SODIUM DODECYL SULFATE; TENASCIN; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TRICHLOROACETIC ACID;

EID: 0031694226     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Wong, J. Y., Mivechi, N. F., Paxton, R. J., Williams, L. E., Beatty, B. G., Beany, J. D., and Shively, J. E. The effects of hyperthermia on tumor carcinoembryonic antigen expression. Int. J. Radiat. Oncol. Biol. Phys., 17: 803-808, 1989.
2. Armour, E. P., Wang, Z., Corry, P. M., and Martinez, A. Sensitization of rat 9L gliosarcoma cells to low dose-rate irradiation by long-duration 41°C hyperthermia. Cancer Res., 51: 3088-3095, 1991.
3. Wang, Z., Armour, E. P., Corry, P. M., and Martinez, A. Elimination of dose-rate effects by mild hyperthermia. Int. J. Radiat. Oncol. Biol. Phys., 24: 965-973, 1992.
4. Stickney, D. R., Gridley, D. S., Kirk, G. A., and Slater, J. M. Enhancement of monoclonal antibody binding to melanoma with single dose radiation or hyperthermia. NCI Monogr., 3: 47-52, 1987.
5. 2 fragment to subcutaneous human glioma xenografts using local hyperthermia. Cancer Res., 50: 1803-1809, 1990.
6. Schuster, J. M., Zalutsky, M. R., Noska, M. A., Dodge, R., Friedman, H. S., Bigner, D. D., and Dewhirst, M. W. Hyperthermic modulation of radiolabelled antibody uptake in human glioma xenograft and normal tissues. Int. J. Hyperth., 11: 59-72, 1995.
7. Hosono, M. N., Hosono, M., Endo, K., Ueda, R., and Onoyama, Y. Effect of hyperthermia on tumor uptake of radiolabeled anti-neural cell adhesion molecule antibody in small-cell lung cancer xenografts. J. Nucl. Med., 35: 504-509, 1994.
8. Hauck, M. L., Dewhirst, M. W., Bigner, D. D., and Zalutsky, M. R. Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model. Clin. Cancer Res., 3: 63-70, 1997.
9. Wilder, R. B., Langmuir, V. K., Mendonca, H. L., Goris, M. L., and Knox, S. J. Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts. Cancer Res., 53: 3022-3027, 1993.
10. Mittal, B. B., Zimmer, A. M., Sathiaseelan, V., Rosen, S. T., Radosevich, J. A., Rademaker, A. W., Saini, A., Pierce, M. C., Webber, D. I., and Spies, S. M. Effects of hyperthermia and iodine-131-labeled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude mice. Cancer (Phila.), 70: 2785-2791, 1992.
11. Hauck, M. L., Dewhirst, M. W., and Zalutsky, M. R. The effects of clinically relevant hyperthermic temperatures on the kinetic binding parameters of a monoclonal antibody. Nucl. Med. Biol., 23: 551-557, 1996.
12. Bourdon, M. A., Wikstrand, C. J., Furthmayr, H., Matthews, T. J., and Bigner, D. D. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res., 43: 2796-2805, 1983.
13. Erickson, H. P., and Bourdon, M. A. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu. Rev. Cell Biol., 5: 71-92, 1989.
14. Ibrahim, E. P., Lightner, V. A., Ventimiglia, J. B., Ibrahim, G. K., Walther, P. J., Bigner, D. D., and Humphrey, P. A. Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma. Hum. Pathol., 24: 982-989, 1993.
15. 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies. Cancer Res., 49: 2807-2813, 1989.
16. Schold, S. C., Zalutsky, M. R., Coleman, R. E., Glantz, M. J., Friedman, A. H., Jaszczak, R. J., Bigner, S. H., and Bigner, D. D. Distribution and dosimetry of I-123-labeled monoclonal antibody 81C6 in patients with anaplastic glioma. Investig. Radiol., 28: 488-496, 1993.
17. 2: a preliminary report. J. Neuro-Oncol., 24: 109-122, 1995.
18. Hauck, M. L., Coffin, D. O., Dodge, R. K., Dewhirst, M. W., Mitchell, J. B., and Zalutsky, M. R. A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumor interstitial pressure. Int. J. Hyperth., 13: 307-316, 1997.
19. 2 fragment labeled using N-succinimidyl 3-iodobenzoate and Iodo-Gen methods. Bioconjug. Chem., 6: 493-501, 1995.
20. 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo. Cancer Res., 55 (Suppl.): 5714s-5720s, 1995.
21. Motta-Hennessy, C., Sharkey, R. M., and Goldenberg, D. M. Metabolism of indium-111-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mouse. J. Nucl. Med., 31: 1510-1519, 1990.
22. Hnatowich, D. J., Mardirossian, G., Rusckowski, M., Fogarasi, M., Virzi, F., and Winnard, P., Jr. Directly and indirectly technetium-99m-labeled antibodies: a comparison of in vitro and animal in vivo properties. J. Nucl. Med., 34: 109-119, 1993.
23. Rogers, B. E., Anderson, C. J., Connett, J. M., Guo, L. W., Edwards, W. B., Sherman, E. L. C., Zinn, K. R., and Welch, M. J. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. Bioconj. Chem., 7: 511-522, 1996.
24. Miller, M. W., and Ziskin, M. C. Biological consequences of hyperthermia. Ultrasound Med. Biol., 15: 707-722, 1989.
25. Bicher, H. I., Hetzel, F. W., Sandhu, T. S., Frinak, S., Vaupel, P., O'Hara, M. D., and O'Brien, T. Effects of hyperthermia on normal and tumor microenvironment. Radiology, 137: 523-530, 1980.
26. 2 and pH response to hyperthermia: dependence on transplant site and duration of treatment. Radiat. Res., 131: 152-156, 1992.
27. Kallinowski, F., and Vaupel, P. Factors governing hyperthermia-induced pH changes in Yoshida sarcomas. Int. J. Hyperth., 5: 641-652, 1989.
28. Kelleher, D. K., Engel, T., and Vaupel, P. W. Changes in microregional perfusion, oxygenation, ATP and lactate distribution in subcutaneous rat tumour upon water-filtered IR-A hyperthermia. Int. J. Hyperth., 11: 241-255, 1995.
29. Lyons, J. C., Kim, G. E., and Song, C. W. Modification of intracellular pH and thermosensitivity. Radiat. Res., 129: 79-87, 1992.
30. Rappaport, D. S., and Song, C. W. Blood flow and intravascular volume of mammary adenocarcinoma 13726A and normal tissues of rat during and following hyperthermia. Int. J. Radiat. Oncol. Biol. Phys., 9: 539-547, 1983.
31. Song, C. W., Lin, J. C., Chelstrom, L. M., and Levitt, S. H. The kinetics of vascular thermotolerance in SCK tumors of A/J mice. J. Radiat. Oncol. Biol. Phys., 17: 799-802, 1989.
32. Song, C. W., Kang, M. S., Juong, G. R., and Levitt, S. H. The effect of hyperthermia on vascular function, pH, and cell survival. Radiol., 137: 795-803, 1980.
33. 31P-NMR spectroscopy of murine tumors before and after localized hyperthermia. Int. J. Hyperth., 6, 15-31, 1990.
34. Salcman, M., and Ebert, P. S. In vitro response of human glioblastoma and canine glioma cells to hyperthermia, radiation and chemotherapy. Neurosurgery (Baltimore), 29: 526-531, 1991.
35. Bullard, D. E., Schold, C. S., Bigner, S. H., and Bigner, D. D. Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. J. Neuropathol. Exp. Neurol., 40: 410-427, 1981.
36. 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model. Cancer Res., 48: 559-566, 1988.
37. He, X., Archer, G. E., Wikstrand, C. J., Morrison, S. L., Zalutsky, M. R., Bigner, D. D., and Batra, S. K. Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin. J. Neuroimmunol., 52: 127-137, 1994.
38. Dangl, J. L., Wensel, T. G., Morrison, S. L., Stryer, L., Herzenberg, L. A., and Oi, V. T. Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J., 7: 1989-1994, 1988.
39. Fraker, P. J., and Speck, J. C. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3α-6α-diphenylglycoluril. Biochem. Biophys. Res. Commun., 80: 849-857, 1978.
40. Reist, C. J., Bigner, D. D., and Zalutsky, M. R. Human IgG2 constant region enhances in vivo stability of anti-tenascin antibody 81C6 compared with its murine parent. Clin. Cancer Res., 4: in press, 1998.
41. Ahern, T. J., and Klibanov, A. M. Analysis of processes causing thermal inactivation of enzymes. Methods Biochem. Anal., 33: 91-127, 1988.
42. Somero, G. N. Proteins and temperature. Annu. Rev. Physiol., 57: 43-68, 1995.
43. Lepock, J. R., Frey, H. E., Heynen, M. P., Nishio, J., Waters, B., Ritchie, K. P., and Kruuv, J. Increased thermostability of thermotolerant CHL V79 cells as determined by differential scanning calorimetry. J. Cell. Physiol., 142: 628-634, 1990.
44. Carlson, N., Rogers, S., and Rechsteiner, M. Microinjection of ubiquitin: changes in protein degradation in HeLa cells subjected to heat-shock. J. Cell Biol., 104: 547-555, 1987.
45. Parsell, D. A., and Lindquist, S. The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu. Rev. Genet., 27: 437-496, 1993.
46. Burel, C., Mezger, V., Pinto, M., Rallu, M., Trigon, S., and Morange, M. Mammalian heat shock protein families: expression and functions. Experientia (Basel), 48: 629-634, 1992.
47. Sapareto, S. A., and Dewey, W. C. Thermal dose determination in cancer therapy. Int. J. Radiat. Oncol. Biol. Phys., 10: 787-800, 1984.
48. Heynen, M., Frey, H. E., Kruuv, J., and Lepock, J. R. Protein degradation in CHL V79 cells during and after exposure to 430°C. Radiat. Res., 119: 73-87, 1989.
49. Zalutsky, M. R., Archer, G. E., Garg, P. K., Batra, S. K., and Bigner, D. D. Chimeric anti-tenascin antibody 81C6: increased tumor localization compared with its murine parent. Nucl. Med. Biol., 23: 449-458, 1996.
50. Pratt, G., Hough, R., and Rechsteiner, M. Proteolysis in heat-stressed HeLa cells. Stabilization of ubiquitin correlates with the loss of proline endopeptidase. J. Biol. Chem., 264: 12526-12532, 1989.
51. Arturson, G. Capillary permeability of the glomerular membrane in clinical burns. Acta Chir. Scand., 274 (Suppl.): 104-108, 1961.
52. Shakespeare, P. G., Coombes, E. J., Hambleton, J., and Furness, D. Proteinuria after burn injury. Ann. Clin. Biochem., 18: 353-360, 1981.
53. Gosling, P., Sutcliffe, A. J., Cooper, M. A. C. S., and Jones, A. F. Burn and trauma associated proteinuria: the role of lipid peroxidation, renin and myoglobin. Ann. Clin. Biochem., 25: 53-59, 1988.